Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

05-09-2023 | Original Paper

VEGF, IGF-1 and FGF-2 Serum Levels in Children and Adolescents with Autism Spectrum Disorder with and without Bipolar Disorder

Auteurs: Gokce Guldiken, Ali Karayagmurlu, Canan Kucukgergin, Murat Coskun

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 10/2024

Abstract

Purpose: To investigate serum levels of VEGF, IGF-1 and FGF-2, and relationships with several clinical characteristics in children and adolescents with autism spectrum disorder (ASD) with and without bipolar disorder (BD). Method: 40 subjects with ASD + BD as study group, and 40 subjects with ASD as control group were included. Serum levels of VEGF, IGF-1, and FGF-2 were measured using commercial enzyme-linked immunosorbent assay kits. Results: The study group was significantly higher than the control group in terms of ASD severity, self-harming behavior and sleep disturbance. Serum VEGF and FGF-2 levels were significantly higher in the ASD + BD group than in the control group. There was no significant difference in serum IGF-1 levels between the two groups. There was no correlation between VEGF, IGF-1 and FGF-2 serum levels and ASD severity in the study group. However there was a negative correlation between VEGF levels and age at first diagnosis of BD, and a positive correlation between IGF-1 levels and the number of bipolar episodes in the study group. Conclusion: Growth factors like VEGF and FGF-2 may be potential biomarkers of bipolar disorder in young subjects with ASD. Given the difficulty of clinical management of BD in young subjects with ASD, potential biomarkers would help clinicians in the diagnosis and follow up of BD in this special population. Further research is needed whether VEGF and FGF-2 can be potential biomarkers in the clinical management of young subjects with ASD and BD.

vorige artikel Intact Utilization of Contextual Information in Speech Categorization in Autism

volgende artikel Adaptive Skills of Individuals with Angelman Syndrome Assessed Using the Vineland Adaptive Behavior Scales, 2nd Edition

Akköprü, H., Alnak, A., Karadoğan, Z. N., Çağlayan, A. O., Özçetin, M., & Coşkun, M. (2023). Peripheral expression of ADORA2A is increased and is correlated with Autism Spectrum Disorder Severity in a sample of turkish children. Psychiatry and Clinical Psychopharmacology, 33(1), 14–19. https://doi.org/10.5152/pcp.2023.22509.CrossRefPubMedPubMedCentral

Alnak, A., Özücer, İ. K., Çağlayan, A. O., & Coşkun, M. (2021). Peripheral expression of MACROD2 gene is reduced among a sample of turkish children with Autism Spectrum Disorder. Psychıatry And Clınıcal Psychopharmacology, 31(3), 261–268. https://doi.org/10.5152/pcp.2021.21144.CrossRefPubMedPubMedCentral

American Psychiatric Association. (2013). Diagnostic and statistical Manual of Mental Disorders, 5th Edition: DSM-5. American Psychiatric Publishing.

Bardach, N. S., Coker, T. R., Zima, B. T., Murphy, J. M., Knapp, P., Richardson, L. P., Edwall, G., & Mangione-Smith, R. (2014). Common and costly hospitalizations for pediatric mental health disorders. Pediatrics, 133(4), 602–609. https://doi.org/10.1542/peds.2013-3165.CrossRefPubMedPubMedCentral

Birmaher, B., Axelson, D., Goldstein, B., Strober, M., Gill, M. K., Hunt, J., Houck, P., Ha, W., Iyengar, S., Kim, E., Yen, S., Hower, H., Esposito-Smythers, C., Goldstein, T., Ryan, N., & Keller, M. (2009). Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The Course and Outcome of Bipolar Youth (COBY) study. The American journal of psychiatry, 166(7), 795–804. https://doi.org/10.1176/appi.ajp.2009.08101569.CrossRefPubMedPubMedCentral

Brent, D., Kaufman, J., Ryan, N., Rao, U., Birmaher, B., Williamson, D., Ryan, N., Version, L., & K-SADS-PL. (2003). (): Initial reliability and Validity Data. Journal of the American Academy of Child & Adolescent Psychiatry, 36(7), 980–988. https://doi.org/10.1097/00004583-199707000-00021.CrossRef

Castillo, M. F. R., Cohen, A., Edberg, D., Hoppensteadt, D., Fareed, J., Martin, B., & Halaris, A. (2020). Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction. Psychiatry Research, 284, 112781.CrossRefPubMed

Chen, M., Zhang, L., & Jiang, Q. (2020). Peripheral IGF-1 in bipolar disorder and major depressive disorder: A systematic review and meta-analysis. Annals of palliative medicine, 9(6), 4044–4053. https://doi.org/10.21037/apm-20-1967.CrossRefPubMed

Cheng, C. M., Reinhardt, R. R., Lee, W. H., Joncas, G., Patel, S. C., & Bondy, C. A. (2000). Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America, 97(18), 10236–10241. https://doi.org/10.1073/pnas.170008497.CrossRefPubMedPubMedCentral

Cirone, C., Secci, I., Favole, I., Ricci, F., Amianto, F., Davico, C., & Vitiello, B. (2021). What do we know about the long-term course of early onset bipolar disorder? A review of the current evidence. Brain sciences, 11(3), 341. https://doi.org/10.3390/brainsci11030341.CrossRefPubMedPubMedCentral

Connor, D. F., Ford, J. D., Pearson, G. S., Scranton, V. L., & Dusad, A. (2017). Early-onset bipolar disorder: Characteristics and outcomes in the clinic. Journal of child and adolescent psychopharmacology, 27(10), 875–883. https://doi.org/10.1089/cap.2017.0058.CrossRefPubMed

Coskun, M., Hajdini, A., Alnak, A., & Karayagmurlu, A. (2020). Internet use habits, parental control and psychiatric comorbidity in young subjects with Asperger syndrome. Journal of Autism and Developmental Disorders, 50, 171–179.CrossRefPubMed

Cross, M. J., & Claesson-Welsh, L. (2001). FGF and VEGF function in angiogenesis: Signalling pathways, biological responses and therapeutic inhibition. Trends in pharmacological sciences, 22(4), 201–207. https://doi.org/10.1016/s0165-6147(00)01676-x.CrossRefPubMed

da Silva, E. G., Pfaffenseller, B., Walz, J., Stertz, L., Fries, G., Rosa, A. R., & Magalhães, P. V. (2017). Peripheral insulin-like growth factor 1 in bipolar disorder. Psychiatry Research, 250, 30–34.CrossRefPubMed

Dono, R., Texido, G., Dussel, R., Ehmke, H., & Zeller, R. (1998). Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. The EMBO journal, 17(15), 4213–4225. https://doi.org/10.1093/emboj/17.15.4213.CrossRefPubMedPubMedCentral

Dunalska, A., Rzeszutek, M., Dębowska, Z., & Bryńska, A. (2021). Comorbidity of bipolar disorder and autism spectrum disorder - review paper. Współwystępowanie choroby afektywnej dwubiegunowej i zaburzeń ze spektrum autyzmu – przegląd badań. Psychiatria polska, 55(6), 1421–1431. https://doi.org/10.12740/PP/OnlineFirst/122350.CrossRefPubMed

Emanuele, E., Orsi, P., Barale, F., di Nemi, S. U., Bertona, M., & Politi, P. (2010). Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism. Clinical biochemistry, 43(3), 317–319.CrossRefPubMed

Ercan, E. S., Polanczyk, G., Akyol Ardıc, U., Yuce, D., Karacetın, G., Tufan, A. E., & Yıldız, N. (2019). The prevalence of childhood psychopathology in Turkey: A cross-sectional multicenter nationwide study (EPICPAT-T). Nordic Journal of Psychiatry, 73(2), 132–140. https://doi.org/10.1080/08039488.2019.1574892.CrossRefPubMed

Esnafoglu, E., & Ayyıldız, S. N. (2017). Decreased levels of serum fibroblast growth factor-2 in children with autism spectrum disorder. Psychiatry research, 257, 79–83. https://doi.org/10.1016/j.psychres.2017.07.028.CrossRefPubMed

Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., & Akil, H. (2004). Dysregulation of the fibroblast growth factor system in major depression. Proceedings of the National Academy of Sciences, 101(43), 15506–15511.

Galvez-Contreras, A. Y., Campos-Ordonez, T., Lopez-Virgen, V., Gomez-Plascencia, J., Ramos-Zuniga, R., & Gonzalez-Perez, O. (2016). Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders. Cytokine & growth factor reviews, 32, 85–96. https://doi.org/10.1016/j.cytogfr.2016.08.004.CrossRef

Ghaziuddin, M., & Ghaziuddin, N. (2021). Bipolar disorder and psychosis in autism. Psychiatric Clinics, 44(1), 1–9.PubMed

Goldstein, B. I., Birmaher, B., Carlson, G. A., DelBello, M. P., Findling, R. L., Fristad, M., Kowatch, R. A., Miklowitz, D. J., Nery, F. G., Perez-Algorta, G., Van Meter, A., Zeni, C. P., Correll, C. U., Kim, H. W., Wozniak, J., Chang, K. D., Hillegers, M., & Youngstrom, E. A. (2017). The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. Bipolar disorders, 19(7), 524–543. https://doi.org/10.1111/bdi.12556.CrossRefPubMedPubMedCentral

Hashimoto, K., Shimizu, E., & Iyo, M. (2004). Critical role of brain-derived neurotrophic factor in mood disorders. Brain research Brain research reviews, 45(2), 104–114. https://doi.org/10.1016/j.brainresrev.2004.02.003.CrossRefPubMed

İncekaş Gassaloğlu, S., Baykara, B., Avcil, S., & Demiral, Y. (2016). Çocukluk Otizmi Derecelendirme Ölçeği Türkçe Formunun Geçerlik ve Güvenilirlik Çalışması [Validity and reliability analysis of turkish version of Childhood Autism Rating Scale]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 27(4), 266–274.PubMed

Iwata, T., & Hevner, R. F. (2009). Fibroblast growth factor signaling in development of the cerebral cortex. Development growth & differentiation, 51(3), 299–323. https://doi.org/10.1111/j.1440-169X.2009.01104.x.CrossRef

Karacetin, G., Arman, A. R., Fis, N. P., Demirci, E., Ozmen, S., Hesapcioglu, S. T., & Ercan, E. S. (2018). Prevalence of childhood affective disorders in Turkey: An epidemiological study. Journal of Affective Disorders, 238, 513–521. https://doi.org/10.1016/j. jad.2018.05.014.CrossRefPubMed

Kaufman, J., Birmaher, B., Axelson, D., et al. (2016). Schedule for affective Disorders and Schizophrenia for School-Aged children: Present and Lifetime Version (K-SADS-PL) DSM-5 November 2016 working draft. New Haven, Yale University, Child and Adolescent Research and Education.

Kim, Y. K., Na, K. S., Hwang, J. A., Yoon, H. K., Lee, H. J., Hahn, S. W., & Jung, H. Y. (2013). High insulin-like growth factor-1 in patients with bipolar I disorder: A trait marker? Journal of affective disorders, 151(2), 738–743.CrossRefPubMed

Kowatch, R. A., Youngstrom, E. A., Danielyan, A., & Findling, R. L. (2005). Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar disorders, 7(6), 483–496. https://doi.org/10.1111/j.1399-5618.2005.00261.x.CrossRefPubMed

Lai, M. C., Kassee, C., Besney, R., Bonato, S., Hull, L., Mandy, W., Szatmari, P., & Ameis, S. H. (2019). Prevalence of co-occurring mental health diagnoses in the autism population: A systematic review and meta-analysis. The lancet Psychiatry, 6(10), 819–829. https://doi.org/10.1016/S2215-0366(19)30289-5.CrossRefPubMed

Lee, B. H., & Kim, Y. K. (2012). Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. Journal of affective disorders, 136(1–2), 181–184. https://doi.org/10.1016/j.jad.2011.07.021.CrossRefPubMed

Liu, X., Zhang, T., He, S., Hong, B., Chen, Z., Peng, D., Wu, Y., Wen, H., Lin, Z., Fang, Y., & Jiang, K. (2014). Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder. Psychiatry research, 218(1–2), 54–60. https://doi.org/10.1016/j.psychres.2014.03.042.CrossRefPubMed

Molteni, R., Fumagalli, F., Magnaghi, V., Roceri, M., Gennarelli, M., Racagni, G., Melcangi, R. C., & Riva, M. A. (2001). Modulation of fibroblast growth factor-2 by stress and corticosteroids: From developmental events to adult brain plasticity. Brain research Brain research reviews, 37(1–3), 249–258. https://doi.org/10.1016/s0165-0173(01)00128-x.CrossRefPubMed

Mutluer, T., Gorker, I., Akdemir, D. E. V. R. M., Ozdemir, D. F., Ozel, O. O., Vural, P., & Ercan, E. S. (2022). Prevalence, comorbidities and mediators of childhood anxiety disorders in urban Turkey: A national representative epidemiological study. Social Psychiatry and Psychiatric Epidemiology, 1–11.

Nurjono, M., Lee, J., & Chong, S. A. (2012). A review of brain-derived neurotrophic factor as a candidate biomarker in Schizophrenia. Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology, 10(2), 61–70. https://doi.org/10.9758/cpn.2012.10.2.61.CrossRefPubMed

O’Kusky, J. R., Ye, P., & D’Ercole, A. J. (2000). Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. The Journal of neuroscience: the official journal of the Society for Neuroscience, 20(22), 8435–8442. https://doi.org/10.1523/JNEUROSCI.20-22-08435.2000.CrossRefPubMed

Palomino, A., González-Pinto, A., Martinez-Cengotitabengoa, M., Ruiz de Azua, S., Alberich, S., Mosquera, F., & Matute, C. (2013). Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Progress in neuro-psychopharmacology & biological psychiatry, 44, 29–33. https://doi.org/10.1016/j.pnpbp.2013.01.008.CrossRef

Pavuluri, M. N., Herbener, E. S., & Sweeney, J. A. (2004). Psychotic symptoms in pediatric bipolar disorder. Journal of affective disorders, 80(1), 19–28. https://doi.org/10.1016/S0165-0327(03)00053-3.CrossRefPubMed

Pillai, A., Howell, K. R., Ahmed, A. O., Weinberg, D., Allen, K. M., Bruggemann, J., Lenroot, R., Liu, D., Galletly, C., Weickert, C. S., & Weickert, T. W. (2016). Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular psychiatry, 21(5), 686–692. https://doi.org/10.1038/mp.2015.96.CrossRefPubMed

Pu, J., Liu, Y., Gui, S., Tian, L., Xu, S., Song, X., Zhong, X., Chen, Y., Chen, X., Yu, Y., Liu, L., Zhang, H., Wang, H., Zhou, C., Zhao, L., & Xie, P. (2020). Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis. Psychiatry research, 292, 113319. https://doi.org/10.1016/j.psychres.2020.113319.CrossRefPubMed

Riva, M. A., Molteni, R., Bedogni, F., Racagni, G., & Fumagalli, F. (2005). Emerging role of the FGF system in psychiatric disorders. Trends in pharmacological sciences, 26(5), 228–231. https://doi.org/10.1016/j.tips.2005.03.001.CrossRefPubMed

Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). Journal of autism and developmental disorders, 10(1), 91–103. https://doi.org/10.1007/BF02408436.CrossRefPubMed

Şimşek, F., Işık, Ü., Aktepe, E., Kılıç, F., Şirin, F. B., & Bozkurt, M. (2021). Comparison of serum VEGF, IGF-1, and HIF-1α levels in children with Autism Spectrum Disorder and healthy controls. Journal of autism and developmental disorders, 51(10), 3564–3574. https://doi.org/10.1007/s10803-020-04820-w.CrossRefPubMed

Skokauskas, N., & Frodl, T. (2015). Overlap between autism spectrum disorder and bipolar affective disorder. Psychopathology, 48(4), 209–216. https://doi.org/10.1159/000435787.CrossRefPubMed

Thapar, A., & Rutter, M. (2021). Genetic advances in autism. Journal of autism and developmental disorders, 51, 4321–4332.CrossRefPubMed

Tu, K. Y., Wu, M. K., Chen, Y. W., Lin, P. Y., Wang, H. Y., Wu, C. K., & Tseng, P. T. (2016). Significantly higher Peripheral insulin-like Growth Factor-1 levels in patients with Major Depressive Disorder or Bipolar Disorder Than in healthy controls: A Meta-Analysis and Review under Guideline of PRISMA. Medicine, 95(4), e2411. https://doi.org/10.1097/MD.0000000000002411.CrossRefPubMedPubMedCentral

Ünal, F., Öktem, F., Çetin Çuhadaroğlu, F., Çengel Kültür, S. E., Akdemir, D., Foto Özdemir, D., Çak, H. T., Ünal, D., Tıraş, K., Aslan, C., Kalaycı, B. M., Aydos, B. S., Kütük, F., Taşyürek, E., Karaokur, R., Karabucak, B., Karakök, B., Karaer, Y., Artık, A., et al. (2019). Okul Çağı Çocukları için Duygulanım Bozuklukları ve Şizofreni Görüşme Çizelgesi-Şimdi ve Yaşam Boyu Şekli-DSM-5 Kasım 2016 -Türkçe Uyarlamasının (ÇDŞG-ŞY-DSM-5-T) Geçerlik ve Güvenirliği [Reliability and validity of the schedule for affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T)]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 30(1), 42–50.PubMed

Titel: VEGF, IGF-1 and FGF-2 Serum Levels in Children and Adolescents with Autism Spectrum Disorder with and without Bipolar Disorder
Auteurs: Gokce Guldiken
Ali Karayagmurlu
Canan Kucukgergin
Murat Coskun
Publicatiedatum: 05-09-2023
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 10/2024
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-023-06089-1

Andere artikelen Uitgave 10/2024

Automated Video Tracking of Autistic Children’s Movement During Caregiver-Child Interaction: An Exploratory Study

Original Paper

Correction: Resting Frontal Gamma Power is Associated with Both Expressive Language and Non-verbal Cognitive Abilities in Young Autistic Children

Correction

Students’ Foreign Language Learning Adaptability and Mental Health Supported by Artificial Intelligence

Original Paper

Adaptive Skills of Individuals with Angelman Syndrome Assessed Using the Vineland Adaptive Behavior Scales, 2nd Edition

Original Paper

Defining the Characteristics of Story Production of Autistic Children: A Multilevel Analysis

Open Access
Original Paper

Refining our Understanding of Anxiety in Autistic Youth: Examining the Role of Behavioral Inflexibility

Original Paper